Clinical Trial Update: The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury [Phase 4]

View source ↗

Summary

Phase 4 trial update on denosumab for secondary osteoporosis in spinal cord injury patients; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Spinal Cord Injury

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Secondary Osteoporosis, Spinal Cord Injury | Phase 4 | Status: TERMINATED